Journal
JOURNAL OF VIRAL HEPATITIS
Volume 27, Issue 9, Pages 904-914Publisher
WILEY
DOI: 10.1111/jvh.13307
Keywords
haemoglobin A(1c); hepatic decompensation; liver neoplasms; liver-related mortality
Funding
- Direct Grant of The Chinese University of Hong Kong [4054345]
Ask authors/readers for more resources
Thiazolidinediones (TZDs) improve glycaemic control and ameliorate liver steatosis, inflammation and fibrosis in patients with fatty liver disease. We aimed to study the impact of TZD and glycaemic control on the risk of hepatocellular carcinoma (HCC) and hepatic events in diabetic patients with chronic hepatitis B (CHB). We performed a retrospective cohort study on diabetic patients with CHB in 2000-2017 using a territory-wide electronic healthcare database in Hong Kong. Diabetes mellitus was identified by use of any antidiabetic medication, haemoglobin A(1c) (HbA(1c)) >= 6.5%, fasting glucose >= 7 mmol/L in two measurements or >= 11.1 mmol/L in one measurement and/or diagnosis codes. Use of antidiabetic medications was modelled as time-dependent covariates. Of 28 999 diabetic patients with CHB, 3963 (13.7%) developed liver-related events (a composite endpoint of HCC and hepatic events) at a median (interquartile range) follow-up of 7.1 (3.7-11.8) years; 1153 patients received TZD during follow-up. After adjusted for important confounders, TZD use was associated with a reduced risk of liver-related events (adjusted hazard ratio [aHR] 0.46, 95% confidence interval [CI] 0.24-0.88; P = .019). Similar trends were observed in HCC (aHR 0.57) and hepatic events (aHR 0.35) separately. Compared to HbA(1c) of 6.5% at baseline, patients with HbA(1c) >= 7% had an increased risk of liver-related events; the risk further increased in 5795 (20.0%) patients with HbA(1c) >= 9% at baseline (aHR 1.14, 95% CI 1.04-1.26; P = .006). TZD use is associated with a lower risk of liver-related events in diabetic patients with CHB. Liver-related events are more common in patients with high HbA(1c) levels.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available